A novel adjuvant for vaccine development in the aged - Wikidata - wikimedia - TriplyDB

A novel adjuvant for vaccine development in the aged

A novel adjuvant for vaccine development in the aged

http://www.wikidata.org/entity/Q34384402

about

Age-dependent dysregulation of innate immunity Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a Immunization of aged pigs with attenuated pseudorabies virus vaccine combined with CpG oligodeoxynucleotide restores defective Th1 immune responses.Novel strategies to enhance vaccine immunity against coccidioidomycosis.Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections.Progress Toward a Human Vaccine Against Coccidioidomycosis Characterization and optimization of the glucan particle-based vaccine platform.

P2860

Q27022410-C74F047E-6D49-44F5-B828-154B0ABBCA91 Q28727437-6C25A19C-0309-424C-AC57-6F1B97448420 Q34778728-6DCDE50F-D04B-49CA-959A-E3F6053A2D04 Q35075092-F24C526F-CF87-42B5-8861-98B7C18E1EA2 Q35589575-5D10041F-8878-44A5-826F-94E106C83824 Q36024806-939CF4AC-3AF6-4DE5-9D1A-E62EB27992F2 Q36315607-47102C21-222B-4367-AA1A-C2ACDFEE272B Q36625631-BF227FC4-B54C-4AB6-ADF4-C2B8E38F2599 Q36749818-0B4402DE-FEAF-4592-9FF8-F6793DE0AC7C Q37252339-A81483AD-5A17-465A-981B-AE02F111DE48

P2860

A novel adjuvant for vaccine development in the aged

http://www.wikidata.org/entity/Q34384402

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A novel adjuvant for vaccine development in the aged

@ast

A novel adjuvant for vaccine development in the aged

@en

A novel adjuvant for vaccine development in the aged

@nl

type

label

A novel adjuvant for vaccine development in the aged

@ast

A novel adjuvant for vaccine development in the aged

@en

A novel adjuvant for vaccine development in the aged

@nl

prefLabel

A novel adjuvant for vaccine development in the aged

@ast

A novel adjuvant for vaccine development in the aged

@en

A novel adjuvant for vaccine development in the aged

@nl

P1433

Q34384402-7C6CFC46-D4B9-467C-9138-1EF122D4AA3F

P1476

Q34384402-3939DA60-998D-4E72-9215-0E05719D9D17

P2093

Q34384402-239044F1-A81A-4770-B8A5-4B41C6741790

Q34384402-50B4E6E7-0484-4E64-BFCA-8E6AE7528F3E

Q34384402-9F95B4B7-98AA-442A-8E8D-04FEEBB9C41E

Q34384402-DC357E95-F557-4209-8B30-0A05AB820FC9

P2860

Q34384402-01AE6CEB-43C3-456E-9633-1BABABBD7D87

Q34384402-02C038F8-55A3-42FE-AC33-F3F67DB35BD7

Q34384402-14EE8CFA-C43E-46DE-9824-66AAB4A30F4E

Q34384402-16E162EF-CB8D-4AFD-9FF7-9113C43038A1

Q34384402-1BFD6A9E-5962-4E26-B0D0-ECC0D9FDC2B4

Q34384402-30FA2F92-E92D-47DB-AE3C-D770FD16FC1D

Q34384402-34D51144-7EA6-4C7C-B0D4-26E77450897C

Q34384402-35FE0F4F-8E8E-4D3F-AB2D-F4DFBBF50CBA

Q34384402-48040050-2212-43E7-8F2E-BB3068118739

Q34384402-48989E56-C342-49AD-9431-F1846AEB1C9C

P304

Q34384402-B1A1711C-FAE2-49A4-BF57-8772E34713EE

P31

Q34384402-F75D0115-7CD7-4FE5-B134-743BC079DBDD

P356

Q34384402-CC878870-1F1B-449E-ABA6-99CC88240AD2

P407

Q34384402-9BA597E6-0E62-4B75-A050-CEA79908A723

P433

Q34384402-4B81B248-D1DA-4D35-BF9E-52D117AD7039

P478

Q34384402-74998F24-5876-42CC-983D-FBF3D783B89A

P577

Q34384402-7472C7D4-F44B-4D20-8F91-867ABAA8C6D7

P5875

Q34384402-4264A28D-1271-4341-B06A-F8CA8EC5F174

P698

Q34384402-59C64457-C46B-48F7-A92C-AFBFD3421B25

P932

Q34384402-22A0BC80-2DDF-40E1-AA29-997025FA47AC

P356

J.VACCINE.2010.10.008

P1433

P1476

A novel adjuvant for vaccine development in the aged

@en

P2093

Edward L Morgan

http://www.w3.org/2001/XMLSchema#string

Joy A Phillips

http://www.w3.org/2001/XMLSchema#string

Marilyn L Thoman

http://www.w3.org/2001/XMLSchema#string

Sam D Sanderson

http://www.w3.org/2001/XMLSchema#string

P2860

Broad-Spectrum Drugs Against Viral Agents

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells

The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.

Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone

Changes in immune function with age.

Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations.

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.

Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels

Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells

Tolerogenic dendritic cells: cytokine modulation comes of age.

P304

8275-8279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2010.10.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47519101

http://www.w3.org/2001/XMLSchema#string

P698

20965299

http://www.w3.org/2001/XMLSchema#string

P932

2997863

http://www.w3.org/2001/XMLSchema#string